HK1212727A1 - 產生免疫調節細胞之方法、依該方法所製備之細胞及其應用 - Google Patents

產生免疫調節細胞之方法、依該方法所製備之細胞及其應用

Info

Publication number
HK1212727A1
HK1212727A1 HK16100442.6A HK16100442A HK1212727A1 HK 1212727 A1 HK1212727 A1 HK 1212727A1 HK 16100442 A HK16100442 A HK 16100442A HK 1212727 A1 HK1212727 A1 HK 1212727A1
Authority
HK
Hong Kong
Prior art keywords
cells
prepared therefrom
generating immunomodulatory
generating
cells prepared
Prior art date
Application number
HK16100442.6A
Other languages
English (en)
Inventor
顏伶汝
劉柯俊
司徒惠康
Original Assignee
Nat Health Research Institutes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Health Research Institutes filed Critical Nat Health Research Institutes
Publication of HK1212727A1 publication Critical patent/HK1212727A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/46434—Antigens related to induction of tolerance to non-self
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C12N5/0637—Immunosuppressive T lymphocytes, e.g. regulatory T cells or Treg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16100442.6A 2012-09-10 2016-01-15 產生免疫調節細胞之方法、依該方法所製備之細胞及其應用 HK1212727A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/607,976 US8927278B2 (en) 2012-09-10 2012-09-10 Method for generating immunomodulatory cells, the cells prepared therefrom, and use thereof
PCT/US2013/058788 WO2014039985A1 (en) 2012-09-10 2013-09-09 Method for generating immunomodulatory cells, the cells prepared therefrom, and use thereof

Publications (1)

Publication Number Publication Date
HK1212727A1 true HK1212727A1 (zh) 2016-06-17

Family

ID=50233866

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16100442.6A HK1212727A1 (zh) 2012-09-10 2016-01-15 產生免疫調節細胞之方法、依該方法所製備之細胞及其應用

Country Status (6)

Country Link
US (1) US8927278B2 (zh)
EP (1) EP2893005B1 (zh)
JP (2) JP6058802B2 (zh)
CN (1) CN104781395B (zh)
HK (1) HK1212727A1 (zh)
WO (1) WO2014039985A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113584116A (zh) * 2021-08-19 2021-11-02 深圳科诺医学检验实验室 一种间充质干细胞免疫调控功能的检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006083289A2 (en) * 2004-06-04 2006-08-10 Duke University Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity
CN101102788A (zh) * 2005-01-24 2008-01-09 克霖固鲁制药股份有限公司 移植器官纤维化抑制剂
CA2913024A1 (en) * 2006-11-03 2008-05-08 Aastrom Biosciences, Inc. Mixed cell populations for tissue repair and separation technique for cell processing
CN101914494A (zh) * 2010-07-27 2010-12-15 郑州大学 经血源性间充质干细胞分离培养及其免疫调节作用
US9352006B2 (en) * 2010-10-20 2016-05-31 Icahn School Of Medicine At Mount Sinai Methods and compositions for treating tumors using myeloid derived suppressor cells

Also Published As

Publication number Publication date
US8927278B2 (en) 2015-01-06
EP2893005A4 (en) 2016-03-09
JP6058802B2 (ja) 2017-01-18
US20140073569A1 (en) 2014-03-13
EP2893005B1 (en) 2018-06-13
EP2893005A1 (en) 2015-07-15
JP2015529086A (ja) 2015-10-05
JP6374924B2 (ja) 2018-08-15
CN104781395A (zh) 2015-07-15
WO2014039985A1 (en) 2014-03-13
CN104781395B (zh) 2019-11-22
JP2017018127A (ja) 2017-01-26

Similar Documents

Publication Publication Date Title
HK1208216A1 (zh) 藥物偶聯物，偶聯方法，及其用途
HK1200879A1 (zh) 鎂合金、其製造方法及其用途
HUE042599T2 (hu) Eljárás szeparátor elkészítésére, az ez által készített szeparátor, és ezzel rendelkezõ elektrokémiai készülék
EP2860963A4 (en) PICTURE GENERATING DEVICE AND PICTURE PRODUCTION METHOD
IL237068A (en) 1,3-dioxanomorphides and 1,3-dioxanocodides
GB201200075D0 (en) Grf3 mutants, methods and plants
EP2816867A4 (en) METHOD FOR ACCESSING A DEVICE, ACCESS POINT, AND ACCESS DEVICE
ZA201500324B (en) Plantsurface structure and modules and method for forming the same
EP2860240A4 (en) APPARATUS FOR CELL CULTURE AND CELL CULTURE METHOD USING THE SAME
HK1216143A1 (zh) 多模態粒子、其方法和用途
EP2843925A4 (en) CHARGING SYSTEM, LOADING DEVICE AND LOADING PROCEDURE
EP2816701A4 (en) ADJUSTMENT DEVICE, BATTERY ARRANGEMENT AND ADJUSTMENT PROCEDURE
EP2938750A4 (en) AMORPHOUS ALLOY AND METHOD FOR MANUFACTURING THE SAME
EP2913391A4 (en) CELL OBSERVATION DEVICE AND CELL OBSERVATION PROCEDURE
EP2586748A4 (en) DEVICE FOR PRODUCING FRESH WATER AND METHOD FOR PRODUCING FRESH WATER
GB201223330D0 (en) Products, methods and uses
EP2813495A4 (en) 2-ARYLBENZOFURAN-7-FORMAMIDE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE THEREOF
HK1175159A1 (zh) 種石墨塊材料及其製備方法
IL234459B (en) Facilities and methods for selecting cells resistant to apoptotic marking and their use
HUE050104T2 (hu) 3,5N-trihidroxi-alkánamid és származékok: eljárás ennek elõállítására és ennek felhasználása
EP2834721A4 (en) METHOD FOR CONTROLLING A DEVICE, AND DEVICE THEREFOR
EP2835521A4 (en) DEVICE FOR CONTROLLING THE POWER GENERATION FOR A SHIP, VESSEL AND METHOD FOR CONTROLLING THE POWER GENERATION FOR A SHIP
HK1212968A1 (zh) 氨基環丁烷衍生物、其製備方法及其用作藥物的用途
HK1209027A1 (zh) 囊泡製劑、用途和方法
EP2935644A4 (en) FILM AND METHOD FOR THE PRODUCTION THEREOF